
Amdova5 mg+10 mg
Beximco Pharmaceuticals Ltd.
Amlodipine + Atorvastatin is a fixed-dose combination indicated in patients for whom treatment with both a calcium channel blocker (amlodipine) and an HMG-CoA reductase inhibitor/statin…
Amlodipine + Atorvastatin is a fixed-dose combination indicated in patients for whom treatment with both a calcium channel blocker (amlodipine) and an HMG-CoA reductase inhibitor/statin (atorvastatin) is considered appropriate.
Amlodipine + Atorvastatin is only appropriate when a patient independently needs both an antihypertensive calcium channel blocker and a statin; it is not intended for patients who need only one of the two components.
Amlodipine + Atorvastatin should always be used alongside diet, exercise, and other lifestyle modifications as advised by a physician.
The dose of Amlodipine + Atorvastatin must be individualized based on the patient's blood pressure control needs and lipid goals, taking into account the effective and tolerated doses of each component when previously used separately.
| Indication | Typical starting dose | Maximum dose |
|---|---|---|
| Hypertension (amlodipine component) | 5 mg once daily | 10 mg once daily |
| Hypercholesterolemia/dyslipidemia (atorvastatin component) | 10–20 mg once daily (up to 40 mg if a large LDL reduction is needed) | 80 mg once daily |
Amlodipine + Atorvastatin tablets are typically available in combinations ranging from amlodipine 5 mg/atorvastatin 10 mg up to amlodipine 10 mg/atorvastatin 80 mg, allowing selection of the combination that matches the patient's individually titrated doses of each component.
When titration of either component is required, allow at least 7 to 14 days between dose adjustments to assess response, unless more rapid titration is clinically indicated (for example, in an inpatient setting with close monitoring).
Take Amlodipine + Atorvastatin once daily, at approximately the same time each day, with or without food. Swallow the tablet whole with a glass of water.
No dosage adjustment of Amlodipine + Atorvastatin is required for renal impairment, as neither amlodipine nor atorvastatin pharmacokinetics are significantly affected by renal function; however, patients on hemodialysis should be monitored as clinically appropriate.
Amlodipine + Atorvastatin should be used with caution in mild-to-moderate hepatic impairment and is contraindicated in active liver disease (see Contraindications). Lower atorvastatin starting doses and close liver enzyme monitoring are advised when hepatic impairment is present.
Most patients tolerate Amlodipine + Atorvastatin well, but side effects can occur from either component.
Contact your physician promptly if you notice any serious or persistent side effects while taking Amlodipine + Atorvastatin.
Amlodipine + Atorvastatin is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.